National Surgical Adjuvant Breast and Bowel Project
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
1993-2003: A Decade of Decadence
Two Steps Forward in the Treatment of Colorectal Cancer
Curative Options for Colorectal Cancer: Folklore, fables, and mythes
Variations on a theme of B (minor)
the FDA approved oxaliplatin
(p=0.71)
INT 0035
NSABP
INT 0035 Dukes B
COMBINED ANALYSIS 11.77-12.90
PATIENT POPULATION
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
'Uncertain indication' for chemotherapy (3239 patients ’94 -’03 MTS 4.6 yrs)
Quasar Survival
Quasar Dukes B Survival
Stage II: Putative Prognostic Discriminates
Gene Identification: C-01/C-02
Gene Identification: C-01/C-02
Survey: N=150 pt with CRC
Survey: N=150 pt with CRC
Survey: N=100 Medical Oncologists
